Clinical trials
Phase 1/2 Small Cell Lung Carcinoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 23andMe, Inc. | 1 |
| AbbVie | 1 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| Gemin X | 1 |
| ImmunoGen, Inc. | 1 |
| Klus Pharma Inc. | 1 |
| Marengo Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 14 |
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Endometrial Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Fallopian Tube Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.